This inventor holds 1 USPTO granted patent. Top assignee: Knoll Aktiengesellschaft. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Kurt Lanthaler: Innovator in Pharmaceutical Emulsions
Introduction
Kurt Lanthaler is a notable inventor based in Poels, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable emulsions for drug administration. His innovative work has led to the creation of a unique formulation that enhances the delivery of active substances.
Latest Patents
Lanthaler holds 1 patent for a stable emulsion suitable for pharmaceutical administration. This patent describes a stable active substance emulsion of the oil-in-water type, utilizing a phospholipid as an emulsifier. The active substance, which is hydrophobic and oil-soluble, is dissolved in the lipid phase and possesses one or more basic groups with a pKa of at least 7.5. The aqueous phase is maintained at an acidic pH, and the disperse phase achieves a positive zeta potential of at least +15 mV, ideally +30 mV, after dilution to a fat content of 0.08% by weight.
Career Highlights
Kurt Lanthaler is associated with Knoll Aktiengesellschaft, a company known for its advancements in pharmaceutical products. His work has been instrumental in developing formulations that improve the efficacy of drug delivery systems.
Collaborations
Lanthaler has collaborated with notable colleagues, including Stanley Stewart Davis and Josef Polzer, contributing to the innovative environment at his workplace.
Conclusion
Kurt Lanthaler's contributions to pharmaceutical emulsions exemplify the impact of innovation in drug delivery systems. His patent reflects a significant advancement in the field, showcasing his dedication to improving pharmaceutical formulations.